Search

everythinglearnresearchcommunity

for

Search:↓

Certain changes in the SHBG gene may increase the risk of PCOS in Iraqi women.

PCOS is a complex condition in women that can lead to health issues, and lifestyle changes are the best management approach.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Some people experience lasting sexual, psychological, and sleep problems after using finasteride or SSRI antidepressants, possibly due to similar underlying causes.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Muscles can make their own androgens, which may help muscle growth.

Women with early-onset baldness should be checked for early bone loss, but bone density doesn't change with baldness severity.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Hair loss causes differ between men and women due to changes in hormone levels and inflammation-related pathways.

Men with frontal male pattern baldness may have a higher risk of gastric cancer.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

A new method accurately measures steroid hormones in a few hair strands and could help study chronic stress and hair loss.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Hormones and genes affect hair growth and male baldness.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

A male with aromatase deficiency improved bone health with estradiol treatment.

The rat model showed early perimenopause with regular cycles and low hormones, and late perimenopause with irregular cycles and higher hormone levels.

Dutasteride, usually used for prostate issues and hair loss, could potentially treat Amyotrophic Lateral Sclerosis (ALS) due to its neuroprotective, antioxidant, and anti-inflammatory properties, but more testing is needed.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Hair loss in women not always linked to increased oil production; other factors may be involved.